Data from: Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy
Su-Young J Jung, Jaeyeol Kwon, Seohyun Park, Jong Hyun Jhee, Hae-Ryong Yun, HyoungNae Kim, Youn Kyung Kee, Chang-Yun Yoon, Tae-Ik Chang, Ea Wha Kang, Jung Tak Park, Tae-Hyun Yoo, Shin-Wook Kang & Seung Hyeok Han
Hyperphosphatemia is associated with mortality in patients with chronic kidney disease, and is common in critically ill patients with acute kidney injury (AKI); however, its clinical implication in these patients is unknown. We conducted an observational study in 1144 patients (mean age, 63.2 years; male, 705 [61.6%]) with AKI who received continuous renal replacement therapy (CRRT) between January 2009 and September 2016. Phosphate levels were measured before (0 h) and 24 h after CRRT initiation....
1 citation reported since publication in 2019.
597 views reported since publication in 2019.
These counts follow the
COUNTER Code of Practice,
meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?
219 downloads reported since publication in 2019.
These counts follow the
COUNTER Code of Practice,
meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?